Q4 EPS Estimates for RenaissanceRe Decreased by Analyst

Key Points

• Zacks Research lowered RenaissanceRe’s Q4 2026 EPS estimate to $8.59 from $8.87. The current full-year 2026 consensus estimate is $41.94 per share.
• RenaissanceRe recently reported quarterly EPS of $12.92 on revenue of $2.77 billion, with a 23.10% return on equity and a 23.65% net margin.
• The stock has a consensus “Hold” rating from analysts and a $336.33 average price target; shares recently opened at $318.06. The company also declared a quarterly dividend of $0.41 per share, yielding approximately 0.5%.

RenaissanceRe Holdings Ltd. (NYSE:RNR - Free Report) - Equities researchers at Zacks Research lowered their Q4 2026 earnings estimates for shares of RenaissanceRe in a report issued on Monday, August 10th. Zacks Research analyst Team now anticipates that the insurance provider will post earnings of $8.59 per share for the quarter, down from their previous forecast of $8.87. The consensus estimate for RenaissanceRe's current full-year earnings is $41.94 per share. Zacks Research also issued estimates for RenaissanceRe's Q1 2027 earnings at $10.69 EPS, Q2 2027 earnings at $12.06 EPS, FY2027 earnings at $39.40 EPS, Q1 2028 earnings at $11.99 EPS, Q2 2028 earnings at $13.29 EPS and FY2028 earnings at $43.77 EPS.

RenaissanceRe (NYSE:RNR - Get Free Report) last released its quarterly earnings results on Tuesday, June 30th. The insurance provider reported $12.92 EPS for the quarter. The company had revenue of $2.77 billion during the quarter. RenaissanceRe had a return on equity of 23.10% and a net margin of 23.65%.

Several other research analysts have also commented on RNR. UBS Group set a $349.00 price target on RenaissanceRe and gave the stock a "neutral" rating in a research report on Monday, July 27th. Mizuho boosted their target price on RenaissanceRe from $325.00 to $329.00 and gave the stock a "neutral" rating in a research note on Thursday, July 9th. Wolfe Research set a $315.00 price target on RenaissanceRe in a research note on Tuesday, July 7th. Cantor Fitzgerald restated an "overweight" rating on shares of RenaissanceRe in a research note on Thursday, July 23rd. Finally, Morgan Stanley lifted their price target on RenaissanceRe from $310.00 to $320.00 and gave the stock an "equal weight" rating in a research report on Monday, July 6th. Five research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $336.33.

RenaissanceRe Stock Performance

Shares of NYSE:RNR opened at $318.06 on Tuesday. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.21. The firm's 50-day moving average is $311.92 and its 200 day moving average is $302.54. RenaissanceRe has a 12 month low of $231.17 and a 12 month high of $335.97. The company has a market capitalization of $13.22 billion, a price-to-earnings ratio of 5.46, a PEG ratio of 1.18 and a beta of 0.17.

Hedge Funds Weigh In On RenaissanceRe

A number of hedge funds have recently made changes to their positions in the stock. BlackRock Inc. purchased a new stake in RenaissanceRe during the 2nd quarter worth approximately $1,319,724,000. Lightrock Netherlands B.V. increased its position in shares of RenaissanceRe by 4,690.1% during the fourth quarter. Lightrock Netherlands B.V. now owns 1,017,508 shares of the insurance provider's stock worth $286,083,000 after acquiring an additional 996,266 shares during the period. Orbis Allan Gray Ltd purchased a new stake in shares of RenaissanceRe during the fourth quarter worth $178,519,000. Norges Bank acquired a new stake in shares of RenaissanceRe in the fourth quarter valued at $168,582,000. Finally, Egerton Capital UK LLP purchased a new position in RenaissanceRe in the fourth quarter valued at $137,944,000. Hedge funds and other institutional investors own 99.97% of the company's stock.

Insider Buying and Selling

In other RenaissanceRe news, EVP Robert Qutub sold 5,000 shares of the firm's stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $333.03, for a total value of $1,665,150.00. Following the completion of the sale, the executive vice president directly owned 72,907 shares of the company's stock, valued at $24,280,218.21. This trade represents a 6.42% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.30% of the company's stock.

RenaissanceRe Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be paid a dividend of $0.41 per share. This represents a $1.64 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Tuesday, September 15th. RenaissanceRe's dividend payout ratio is currently 2.81%.

About RenaissanceRe

RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance solutions, specializing in property catastrophe, casualty, and specialty lines. Established in 1993 and headquartered in Bermuda, the company trades on the New York Stock Exchange under the symbol RNR. With a focus on underwriting and risk assessment, RenaissanceRe offers tailored programs designed to help insurers and corporations manage exposure to natural disasters, liability claims, and other complex risks.

The company operates through two primary segments: Reinsurance and Insurance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source